Figure 2 | British Journal of Cancer

Figure 2

From: Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT)

Figure 2

Hydroxylapatite chromatography of ST2146 (A) and BC4 (B). SDS–PAGE analysis under reducing conditions of ST2146 not digested (C, lane 1) or digested with sialidase (C, lane 2) and BC4 peaks 1, 2 or 3 from hydroxylapatite chromatography (D, P1, P2 and P3, respectively). Note: The dotted chain was found to be not functional. Therefore, divalent BC4 corresponds only to peak 3.

Back to article page